SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverJHPCY
HealthcarePNKUSD

JHPCY

$0012345678900123456789.0012345678900123456789+15.0%
52w low (est.) $13.04$19.17 52w high (est.)
Market data
Market cap
USD45.13B
52-week range
USD13.60 – USD18.00
Beta (vs market)
0.12
Sector
Healthcare
Data quality
100/100
Valuation
P/E ratio
37.8x
DCF fair value
USD10.24
Margin of safety
-34.5%
Dividend yield
0.43%
Quality & efficiency
Moat score
82/100
Return on equity
14.5%
Profit margin
24.9%
Growth & analysts
Revenue growth (YoY)
+13.0%

About JHPCY

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

Valuation

ValueGrowthProfitHealthIncome47QUALITY
Overall Rating
49
Hold
Hold

Derived from filed metrics · High confidence (100% of the inputs available)

Moat Score82
DCF Intrinsic Value
USD10.24-34.5% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD45.13B
P/E Ratio
37.8
Dividend Yield
0.43%
Revenue Growth
+13.0%
Profit Margin
24.9%
ROE
14.5%
Debt / Equity
0.00
Beta
0.12
vs Healthcare sector:P/E 38 vs 28 Moat 82 vs 7Yield 0.43% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · JHPCY